Navigation Links
Pearl Therapeutics Announces Successful Completion of Phase 2b Safety and Efficacy Studies of COPD Combination, PT003
Date:1/6/2012

study of PT003 compared with its components and marketed bronchodilators, Foradil® Aerolizer® and Spiriva® HandiHaler®. Approximately 700 patients with moderate-to-severe COPD have taken part in Pearl's Phase 2b clinical program to date.

"The totality of findings from our clinical program to date, which includes five Phase 2b studies, two Phase 1/2a studies and one Phase 1 study, present a strong foundation on which we plan to build a comprehensive Phase 3 program to support regulatory approval of PT003," added Dr. Colin Reisner, chief medical officer and executive vice president of clinical development for Pearl Therapeutics. "I believe the world-class team of pulmonary drug development specialists that we have assembled, and our proven ability to conduct well-controlled and highly informative trials will provide the regulatory support needed to make our bronchodilator product family available for the very large patient population which suffers from the debilitating effects of COPD."

About COPD

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable lung disease that is the fourth leading cause of death in the United States. Each year 12 million Americans are diagnosed with COPD and an additional 12 million Americans may have COPD but remain undiagnosed. Research shows that many do not get optimal treatment.

Bronchodilator medications are central to symptom management and are prescribed on an as-needed or regular basis to prevent or reduce symptoms. Long-acting inhaled bronchodilators have been shown to be most effective and convenient. Combining bronchodilators of different pharmacological classes, as recommended by The Global Initiative for Chronic Obstructive Lung Diseases (GOLD), has been shown to improve efficacy and may decrease the risk of side effec
'/>"/>

SOURCE Pearl Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
2. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
3. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
4. Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
5. Pearl Therapeutics Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD
6. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
7. Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
8. Pearl Therapeutics Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
9. Anthera Announces Last Patient Enrolled in PEARL-SC Study
10. Pearl Therapeutics Presents New Scientific Evidence Supporting Versatility of Its Novel Cosuspension MDI Platform
11. Pearl Therapeutics Reports Positive Phase 2b Results of PT001 in Patients With COPD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)...  Decision Resources Group finds that the Asia Pacific ... China , India , ... through 2023. Dental implant procedure volumes will grow as physicians are ... Other key findings from Decision Resources Group,s coverage of the ... , Dental implant penetration: Penetration of dental implants among the ...
(Date:9/30/2014)... -- Alimera Sciences, Inc. (NASDAQ: ALIM ) (Alimera), ... and commercialization of prescription ophthalmic pharmaceuticals, announced today that ... Technology Growth Capital, Inc. (NYSE: HTGC ) ... under the Loan and Security Agreement that Alimera,s subsidiary ... Sciences Limited, entered into with Hercules in April of ...
(Date:9/30/2014)... 2014 The Chinese wound care market is ... in the incidence of lifestyle diseases, coupled with the ... of better quality of wound care products provide the ... of public health insurance schemes and increased reimbursement rate ... on the findings of primary and secondary researches, this ...
Breaking Medicine Technology:Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2China Wound Care Market 2China Wound Care Market 3
... HAYWARD, Calif., Feb. 1, 2011 Anthera Pharmaceuticals, Inc. ... drugs to treat serious diseases associated with abnormal auto-immune ... Dr. Peter Thompson to its Board of Directors. Currently, ... is the founder and Managing Director of Strategicon Partners, ...
... Mich., Feb. 1, 2011 Stryker Corporation (NYSE: ... previously announced sale of its OP-1 product family, which ... use in orthopaedic bone applications. The transaction also includes ... Stryker is one of the world,s ...
Cached Medicine Technology:Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors 2
(Date:10/1/2014)... Raleigh, NC (PRWEB) October 01, 2014 ... combination of three drugs that target immune system proteins ... Surviving Mesothelioma has just posted details of the new ... the story now. , Researchers in the UWA ... TGF-ß, and anti-CTLA-4 drugs to mice with mesothelioma with ...
(Date:10/1/2014)... at the occasion of the Leishmaniasis East Africa ... and international leishmaniasis experts, results of a pharmacovigilance ... plan, carried out by MSF, DNDi, and ... were presented to key decision makers in order ... with the combination of Sodium Stibogluconate and Paromomycin ...
(Date:10/1/2014)... October is national Breast Cancer Awareness ... plans while raising money for breast cancer research. Pelican ... Month in the effort to find a cure. ... importance of having access to clean, healthy water. Research ... to certain forms of cancer. , The Problem ...
(Date:10/1/2014)... Dr. Saj Jivraj, one of the world’s ... to Chennai, India, tomorrow to speak at the Indian ... , Dr. Jivraj is founder of the Anacapa Dental ... one of the world’s foremost prosthodontists, meaning he is ... speaking to the Indian Society of Oral Implantologists about ...
(Date:10/1/2014)... WA (PRWEB) October 01, 2014 Two ... will take them across the country in an effort ... today’s military families. The cyclists, a father-daughter team, ... states, beginning in Blaine, Washington and finishing in Key ... benefit Hope For The Warriors®, a national nonprofit organization ...
Breaking Medicine News(10 mins):Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 3Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 4Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 5Health News:Father-Daughter Cycling Duo to Ride Cross-Country to Benefit Hope For The Warriors 2
... than cancer itself. A patient may respond to one ... and stop responding to the drug -- resulting in months ... , Now UCLA scientists have tested a non-invasive approach ... response to a drug before prescribing therapy, enabling physicians to ...
... a first-ever procedure, surgeons at Johns Hopkins have successfully ... in the back of the donor,s vagina. , "The ... niece, and both patients are doing fine," says Robert ... Johns Hopkins University School of Medicine who led the ...
... ANDS ) announced today that it will present ... Monday, February 9, 2009 at 11:00 a.m. EST (8:00 a.m. ... Hotel in New York. Steve Worland, Ph.D., President and ... Anadys and an update on its clinical programs: ANA598 ...
... 2 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ... conference call with simultaneous webcast on Tuesday, February 3, ... Members of Rigel,s senior management team will provide an ... Call and Webcast Information To access the live call, ...
... to Capture and Automate Faxes to Enhance Productivity and Facilitate Regulatory ... ... -- FaxBack® , the high-density VoIP fax leader for Enterprise, ... Integration Server , an easy-to-install plug-in that turns fax machines into ...
... First Quarter EPS and Adjusted EPS Despite a Challenging Economic ... the Company) (Nasdaq: HOLX ), a leading developer, ... surgical products dedicated to serving the healthcare needs of women, ... 2008. Highlights of the quarter include: ...
Cached Medicine News:Health News:UCLA scientists develop crystal ball for personalized cancer treatment 2Health News:Hopkins transplant surgeons remove healthy kidney through donor's vagina 2Health News:Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference 2Health News:Rigel to Host Conference Call on February 3, 2009 2Health News:FaxBack Enables Fax Machine Integration With Document Management Systems 2Health News:FaxBack Enables Fax Machine Integration With Document Management Systems 3Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 2Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 3Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 4Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 5Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 6Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 7Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 8Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 9Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 10Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 11Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 12Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 13Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 14Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 15Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 16Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 17
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: